MPLT EPS Estimates
MapLight Therapeutics, Inc.
$8.22
+$0.41(+5.26%)
20
Overall
--
Value
27
Tech
13
Quality
Market Cap
$510.09M
Volume
91.45K
52W Range
$8.70 - $40.43
Target Price
$27.15
MPLT EPS estimates: the consensus estimate for MapLight Therapeutics, Inc.'s current fiscal year is -$5.01 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
MPLT EPS Estimates
- EPS estimate, current quarter
- $-1.22
- EPS estimate, next quarter
- $-1.15
- EPS estimate, current year
- $-5.01
- EPS estimate, next year
- $-4.12
- EPS growth, 3-year
- -79.48%
| Fiscal year | EPS |
|---|---|
| 2025 | $-18.56 |
| 2024 | $-105.38 |
| 2023 | $-5.03 |
| 2022 | $-3.21 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MPLT | $8.22 | +5.3% | 91.45K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get MapLight Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW